cnsdose - map16 demo day pitch
Post on 11-Apr-2017
47 Views
Preview:
TRANSCRIPT
cnsdose.
TRIAL &ERROR
cnsdose.
FAST-TRACKFINDING THE RIGHT ANTIDEPRESSANT
WORLD FIRST EVIDENCE RANDOMISED CONTROLLED TRIAL
cnsdose.GUIDED PRESCRIBINGUNGUIDED PRESCRIBING
28% REMISSION 72% REMISSION
EASY 3 STEP PROCESS
STEP 1 SEE YOUR DOCTOR
STEP 2 DNA TEST
(VIA GENETIC LAB)
STEP 3 REPORT GENERATED
DISTRIBUTION PARTNERS
PGAHEALTHCARE
COST TO PATIENT
$090% of Patients
DR HARRIS EYRE MDCo-Founder
Chief Medical Officer
A/PROF AJEET B SINGHFounder
CEO
CAMPBELL WALSHECo-Founder
Chief Operating Officer
THE TEAM
HON ANDREW ROBB AOFormer Federal Trade Minister
PROFESSOR JOHN TILLERMD PhD DPM FRANZCP
GAICD FRACP MBBSEmeritus Professor,
Department of Psychiatry University of Melbourne
MARK HEINEMEYER, MSCSerial MedTech Entrepreneur
ADVISORY BOARD
SEEKING INTERESTED INVESTORS FOR DECEMBER 2016
top related